Clinical Testing Services
Clinical Testing Services
Xiaoyukang series
Xiaoyukang series
Gene test for clinical medication for hepatobiliary and pancreatic tumors
Gene test for clinical medication for hepatobiliary and pancreatic tumors

The Xiaoyukang series cover 150 genes related to targeted drugs, chemotherapy drugs and genetic risks. Using next-generation sequencing (NGS) technology of target gene capture, it comprehensively and accurately detects target gene capture exons and single nucleotide variations (SNV), short fragment insertion or deletion variations (InDel), gene copy number variations (CNV) and gene rearrangement/fusion within the intron range of standard spliceosomes, to provide reference and guidance for clinical medication and genetic risk of patients with hepatobiliary and pancreatic tumors.

Product Advantages

▪ Covers 43 genes related to targeted therapy of hepatobiliary and pancreatic tumors that have been approved by FDA/NMPA, recommended in NCCN guidelines, or have shown clinically significant potential in clinical trials, and evaluates multiple targeted drugs for hepatobiliary and pancreatic tumors that have been approved or in phase II/III clinical trials

▪ Covers 16 HRR genes and assesses the efficacy of PARP inhibitors

▪ Covers 108 chemotherapy genes related to Asian/Chinese populations and assesses the efficacy and toxicity risks of chemotherapy drugs

▪ Covers the germline interpretation of 17 genes and prompts genetic risks

▪  The mutation information is accurately described according to the HGVS standard terms. The germline genetic mutations are classified according to the ACMG guidelines for the classification of the pathogenicity of mutations, and the clinical medication is suggested based on clinical based medical evidence

▪ Ultra-high depth sequencing and the limit of detection of ctDNA is 0.1%

Product List
Xiaoyukang (Basic Edition)
Test of 150 genes for clinical medication for hepatobiliary and pancreatic tumors
Xiaoyukang (Basic Edition) NI
Test of 150 genes for clinical medication for hepatobiliary and pancreatic tumors (blood edition)
Xiaoyukang (Basic Edition) TY
Test of 150 genes for clinical medication for hepatobiliary and pancreatic tumors (body fluid edition)
Top